Singapore markets closed

WPD Pharmaceuticals Inc. (WBIO.CN)

Canadian Sec - Canadian Sec Real-time price. Currency in CAD
Add to watchlist
0.01500.0000 (0.00%)
At close: 09:30AM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 1.72M
Enterprise value 2.03M
Trailing P/E 0.41
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.61

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-66.67%
S&P500 52-week change 326.24%
52-week high 30.0450
52-week low 30.0050
50-day moving average 30.0366
200-day moving average 30.0429

Share statistics

Avg vol (3-month) 35.34k
Avg vol (10-day) 3791
Shares outstanding 5114.82M
Implied shares outstanding 6114.82M
Float 8113.31M
% held by insiders 139.62%
% held by institutions 10.00%
Shares short (31 May 2022) 4191
Short ratio (31 May 2022) 40.15
Short % of float (31 May 2022) 4N/A
Short % of shares outstanding (31 May 2022) 40.00%
Shares short (prior month 29 Apr 2022) 425.19k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 317 Jul 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-105.71%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -299.89k
Net income avi to common (ttm)-199.73k
Diluted EPS (ttm)0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.84k
Total cash per share (mrq)0
Total debt (mrq)321.98k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.08
Book value per share (mrq)-0.01

Cash flow statement

Operating cash flow (ttm)-259.34k
Levered free cash flow (ttm)-100.74k